Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Upgraded by Citizens Jmp
Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) was upgraded by equities researchers at Citizens Jmp from a “market perform” rating to a “market outperform” rating in a research note issued on Monday,Benzinga reports. The brokerage currently has a $8.00 price target on the biotechnology company’s stock. Citizens Jmp’s price objective points to a potential upside [...]